Testing effectiveness (Phase 2)Study completedNCT00639769
What this trial is testing
Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 41